ArticlePDF Available

Constipation in intensive care unit: Incidence and risk factors

Authors:

Abstract and Figures

Although gastrointestinal motility disorders are common in critically ill patients, constipation and its implications have received very little attention. We aimed to determine the incidence of constipation to find risk factors and its implications in critically ill patients During a 6-month period, we enrolled all patients admitted to an intensive care unit from an universitary hospital who stayed 3 or more days. Patients submitted to bowel surgery were excluded. Constipation occurred in 69.9% of the patients. There was no difference between constipated and not constipated in terms of sex, age, Acute Physiology and Chronic Health Evaluation II, type of admission (surgical, clinical, or trauma), opiate use, antibiotic therapy, and mechanical ventilation. Early (<24 hours) enteral nutrition was associated with less constipation, a finding that persisted at multivariable analysis (P < .01). Constipation was not associated with greater intensive care unit or mortality, length of stay, or days free from mechanical ventilation. Constipation is very common among critically ill patients. Early enteral nutrition is associated with earlier return of bowel function.
Content may be subject to copyright.
Constipation in intensive care unit: Incidence and
risk factors
Antonio Paulo Nassar Jr. MD
a,
, Fernanda Maria Queiroz da Silva MD
a
,
Roberto de Cleva PhD
b
a
Department of Medicine, Discipline of Medical Emergencies, University of São Paulo, São Paulo-SP CEP 02402-400, Brazil
b
Department of Gastroenterology, University of São Paulo, São Paulo-SP CEP 02402-400, Brazil
Keywords:
Constipation;
Gastrointestinal motility;
Critical care;
Critically ill;
Enteral nutrition
Abstract
Purpose: Although gastrointestinal motility disorders are common in critically ill patients, constipation
and its implications have received very little attention. We aimed to determine the incidence of
constipation to find risk factors and its implications in critically ill patients
Materials and Methods: During a 6-month period, we enrolled all patients admitted to an intensive
care unit from an universitary hospital who stayed 3 or more days. Patients submitted to bowel surgery
were excluded.
Results: Constipation occurred in 69.9% of the patients. There was no difference between constipated
and not constipated in terms of sex, age, Acute Physiology and Chronic Health Evaluation II, type of
admission (surgical, clinical, or trauma), opiate use, antibiotic therapy, and mechanical ventilation.
Early (b24 hours) enteral nutrition was associated with less constipation, a finding that persisted at
multivariable analysis (Pb.01). Constipation was not associated with greater intensive care unit or
mortality, length of stay, or days free from mechanical ventilation.
Conclusions: Constipation is very common among critically ill patients. Early enteral nutrition is
associated with earlier return of bowel function.
© 2009 Elsevier Inc. All rights reserved.
1. Introduction
Gastrointestinal motility disturbances are common in
critically ill patients [1,2]. Abnormalities in gastric emptying
[3] and diarrhea [4] are well studied and have a considerable
impact in critically ill patients' prognoses. However,
constipation has received much less attention in clinical
studies. Outside the intensive care unit (ICU) setting,
constipation is a common symptom, affecting 2% to 27%
of the population [5]. It seems that constipation has great
implications in quality of life outside the ICU [6], but it was
not a symptom reported in ICU patients' surveys [7,8].
There is not a homogeneous definition of constipation
across studies. It has been defined as absence of bowel
movements within 3 [9],6[11],or9[10] days without bowel
movements and either as need for treatment with laxatives or
enemas according to the attending physician [12]. Conse-
quently, the incidence of constipation in ICU setting is
Corresponding author.
E-mail address: paulo_nassar@yahoo.com.br (A.P. Nassar).
0883-9441/$ see front matter © 2009 Elsevier Inc. All rights reserved.
doi:10.1016/j.jcrc.2009.03.007
Journal of Critical Care (2009) 24, 630.e9630.e12
variable, ranging from 15% to 83% [9-12],probably
according to the sensitivity of the chosen criteria.
There are few studies addressing constipation as a specific
problem. Observational studies have found a correlation
between constipation, organ dysfunction, prolonged length
of stay, and failure to wean from mechanical ventilation,
although results diverge among studies [9,11].
There are many factors that may contribute to constipation
in critically ill patients. Shock causes splanchnic hypoperfu-
sion, which is associated with impaired gastrointestinal
motility. Electrolyte disturbances, mainly hypokalemia and
hypomagnesemia, are also associated with decreased
intestinal motility. Some drugs commonly used in ICU
may also be involved. Opiates, which are the commonest
prescribed analgesics in ICU, inhibit intestinal motility and
have a venodilator property that can decrease venous return
and, maybe, impair perfusion to a great level [1].
Fecal stasis induces overgrowth of gram-negative bacteria
in the digestive tract. Translocation of bacteria and
endotoxins may lead to infections and enhanced systemic
inflammatory response [13].
The aim of our study is to determine the incidence of
constipation in a surgical ICU to find risk factors and its
implications in critically ill patients.
2. Methods
2.1. Study subjects
We conducted a survey in a surgical ICU of a university
hospital. Our ICU is a 14-bed unit that receives immediate
postoperative and patients from surgical wards with medical
problems. All patients admitted to the ICU and who stayed
for 3 or more days in ICU were included in the study. We
choose this criterion because the first study that addressed
constipation in ICU setting defined constipation as a failure
of bowel to function for 3 consecutive days[9]. Patients
were excluded if they did not stay in ICU for 3 or more days
because of rapid recovery or death. Bowel surgery patients
were also excluded. The study was approved by local ethics
committee. Because all data were collected from patient
records and there was no influence on patients' treatment,
informed consent was waived.
2.2. Study protocol
We collected the following data from all patients: age,
sex, reason for admission (medical, surgical, and type of
surgery, or trauma), Acute Physiology and Chronic Health
Evaluation II (APACHE II) score, antibiotic therapy, opiate
use, early enteral nutrition (before or after 24 hours from ICU
admission), use of renal replacement therapy, days free of
mechanical ventilation at day 28, length of stay in ICU, ICU
mortality, and hospital mortality.
For patients requiring mechanical ventilation, midazolam
and fentanyl were continuously infused in 2 separated
pumps aiming a Ramsay sedation score of 2 to 3 [14] at
discretion of the attending physician. It is practice in this
unit to proceed with a daily wakeningduring nursing
morning changing shifts (7 AM). Enteral nutrition was
initiated in all patients at discretion of the attending
physician. There is no specific protocol to begin enteral
nutrition. It is not common practice in our unit to use
laxatives or fecal emollients, but data regarding these
medications was recorded.
Weaning from mechanical ventilation is initiated when
patients are hemodynamically stable, have an adequate
level of conscience (Glasgow Coma Score N8), a PaO
2
/FiO
2
relation greater than 150 with an FiO
2
less than 40% and a
positive end-expiratory pressure lower than 8 cm H
2
O, and
an adequate cough reflex [15], as evaluated by physiother-
apy team.
All data were prospectively collected daily by 2 trained
researchers (APNJ and FMQS) from patients' charts and
were inserted in an electronic database.
2.3. Statistical analyses
All continuous variables are presented as medians and
interquartile ranges (IQRs) and were compared with Mann-
Whitney test. Categoric variables are presented as percen-
tages and were compared with χ
2
or Fisher exact test, as
appropriate. The following variables were entered in a
logistic regression analysis to find factors independently
associated with constipation: age, sex, reason for admission
(surgical vs not surgical), opiate use, previous antibiotic use,
and early enteral nutrition. All statistics were 2 tailed, and a
Pb.05 was considered to be significant. All analyses were
performed using SPSS version 10.0 (SPSS, Chicago, Ill).
3. Results
A total of 371 patients were admitted during the study
period (February to July 2006). Eighty-eight patients were
excluded because of bowel surgery and 177 patients because
of staying less than 3 days. A total of 106 patients fulfilled
study criteria. These patients were predominantly male
(64.2%), 61 (IQR, 50-72) years old, and with an APACHE II
of 18 (IQR, 12-22).
Seventy-six patients (71.7%) were admitted intubated,
with a median of days free from mechanical ventilation of
13.5 (IQR, 0-24). Intensive care unit mortality was of 37.7%
and hospital mortality of 46.2%.
Sixty-three patients (59.5%) were admitted directly from
the surgery. Gastrointestinal surgery was performed in 45
patients (42.5%). Other types of surgery were vascular
(6.6%), head and neck surgery (3.8%), neurosurgery
(2.8%), urologic (1.9%), and plastic (1.9%). Thirty-eight
630.e10 A.P. Nassar Jr. et al.
(35.8%) patients were admitted for medical reasons and 5
(4.7%) for trauma.
A total of 73 (69.9%) patients were considered con-
stipated according to the definition chosen. No patient used
laxatives or fecal emollients during the first 3 days in ICU. At
univariate analysis, early enteral nutrition was negatively
associated with constipation (Table 1). There was a trend
toward constipation among surgical patients when compared
exclusively with medical patients, although it did not reach
statistical significance (47 patients [74.6%] vs 21 patients
[48.5%], P= .07). There were also no differences between
surgical and trauma patients (47 patients [74.6%] vs 5
patients [100%], P= .33) or medical and trauma patients (21
patients [48.5%] vs 5 patients [100%], P= .14). Among
surgical patients, constipation was not more frequent in
gastrointestinal surgery patients than in patients submitted to
other types of surgery (34 patients [75.5%] vs 13 patients
[72.2%], P= .76).
When logistic regression analysis was performed, the
only variable independently associated with constipation
continued to be enteral nutrition (odds ratio, 0.16; 95%
confidence interval, 0.05-0.45; Pb.001).
Constipation was not associated with any complication as
can be seen in Table 2.
4. Discussion
Constipation is still a poorly understood complication of
critically ill patients. To the best of our knowledge, there
were only 5 studies that addressed this question [9-13,16].
Two were observational trials that addressed specifically the
impact of constipation in critically ill patients [9,11], 2 were
trials that tested specific therapies to constipation [10,16],
and the last was a trial that intended to find the complications
of enteral nutrition in critically ill patients, and constipation
was one of the least important (15%) [12]. The largest trial
addressing constipation was a randomized trial recently
published that compared lactulose and ethylene glycol with
the specific aim to find which drug could cause an increase in
defecation among patients enrolled [16]. Our study is the
largest observational trial that intended to find risk factors
and implications of constipation on patients' outcomes.
Although there was a variable incidence reported, it
seems it is a very common problem. In a cohort of 44
patients from a clinical study of selective gastrointestinal
decontamination, the mean time from admission to the first
defecation was 6 days. This study showed that patients had
no bowel movement during 56.6% of their ICU stay [11].
Our study found an incidence of almost 70%, using a
definition previously used of 3 days without a bowel
movement [9]. We have used this definition because it may
be the most sensitive.
Our study was the first to demonstrate that the early
beginning of enteral nutrition is associated with a decreased
incidence of constipation. Experimental and clinical studies
have demonstrated that enteral nutrition better preserves the
gastrointestinal mucosal structure and function [17]. There-
fore, defecation may be seen as a sign of preservation of
gastrointestinal function. Because there is a tendency to face
impaired gastrointestinal motility as a manifestation of
multiple organ dysfunctions, early enteral nutrition may be
seen as a protective factor.
Another interesting finding of our study was that opiate
use was not associated with an increased incidence of
constipation. One possible explanation is that the opiate used
in our unit is fentanyl. Studies that have shown association
between opiates and constipation used morphine [10,11,16].
At least for treatment of cancer pain, fentanyl is associated
with less constipation than morphine [18,19]. This finding
must be prospectively evaluated in critically ill patients
before any conclusion be made.
Antibiotic therapy was not associated with either increase
or decrease in incidence of constipation.
Other clinical trials demonstrated that constipation was
associated with failure to wean from mechanical ventilation
[9], increased length of stay, higher severity of illness, higher
mean doses of vasopressors, more days on mechanical
ventilation [11], and increased mortality [16]. We did not
find these associations in our cohort. This may be in part of
some differences among our and the other trials cited. We did
not search for failure to wean from mechanical ventilation.
Although median free days from mechanical ventilation were
Table 1 Baseline patients' characteristics
a
Constipated
(n = 73)
Not constipated
(n = 33)
P
Age 59 (49-72) 64 (51-70.5) .53
Male sex 44 (60.3) 24 (72.7) .31
APACHE II 18 (12-22) 18 (12-21.5) .88
Opiate use 47 (64.4) 19 (57.6) .65
Antibioticotherapy 53 (75.7) 22 (66.7) .70
Mechanical ventilation 53 (72.6) 23 (69.7) .94
Early enteral diet 14 (19.2) 19 (57.6) b.01
a
All continuous data are presented as medians (IQR), and all
categoric data are presented as numbers (percentages).
Table 2 Implications of constipation in critically ill patients'
clinical outcomes
a
Constipated
(n = 73)
Not constipated
(n = 33)
P
Renal replacement therapy 17 (23.3) 5 (15.2) .41
Days free of mechanical
ventilation at day 28
11 (0-23.5) 17 (0-25) .54
ICU length of stay (d) 8 (5-16.5) 6 (4-13.5) .35
ICU mortality 29 (39.7) 11 (33.3) .68
Hospital mortality 31 (42.5) 18 (54.5) .25
a
All continuous data are presented as medians (IQR), and all categoric
data are presented as numbers (percentages).
630.e11Constipation in ICU: Incidence and risk factors
not different between constipated and nonconstipated
patients in our cohort, maybe constipated patients have had
more failure attempts to wean and could have less days on
mechanical ventilation. Mortality attributed to constipation
was increased only in a recent clinical trial addressing the
effect of 2 laxatives in critically ill patient [16]. The authors
found on a logistic regression analysis that not producing
stools when on study medication was independently
associated with in-hospital mortality. This finding, although
interesting, must be interpreted with caution. First, it was not
constipation per se associated with an increased mortality,
but failure to defecate when using study medications
(lactulose and polyethylene glycol). Second, it was found
on a multivariate analysis and was not the primary outcome
of this study. However, it is a tempting hypothesis that
deserves to be studied.
Our study has obvious several limitations. First, it has an
observational design. Therefore, it has all limitations
commonly implied with this kind of study. Most importantly,
no finding here can be interpreted as causal relationship.
Second, many data cited in other studies were not available.
Of note, we cite the use of vasoactive agents.
In conclusion, our study shows that constipation was a
common event in this cohort of critically ill patients.
However, it was not associated with any adverse outcome.
The early beginning of enteral nutrition was associated with
an earlier return of bowel function. More studies are
necessary to definitively assess the course of bowel function
in critically ill patients and when it can affect outcomes.
References
[1] Fruhwald S, Holzer P, Metzler H. Intestinal motility disturbances in
intensive care patients' pathogenesis and clinical impact. Intensive
Care Med 2007;33:36-44.
[2] Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving
mechanical ventilation. Chest 2001;119:1222-41.
[3] Nguyen NQ, Ng MP, Chapman M, et al. The impact of admission
diagnosis on gastric emptying in critically ill patients. Crit Care 2006;
11:R16.
[4] Wiesen P, Van Gossum A, Preiser JC. Diarrhoea in critically ill. Curr
Opin Crit Care 2006;12:149-54.
[5] Lembo A, Camilleri M. Chronic constipation. N Engl J Med 2003;349:
1360-8.
[6] Wald A, Scarpignato C, Kamm MA, et al. The burden of constipation
on quality of life: results of a multinational survey. Aliment Pharmacol
Ther 2007;26:227-36.
[7] Novaes MAFP, Knobel E,Bork AM, et al. Stressors in ICU: perception
of the patient, relatives and health care team. Intensive Care Med
1999;25:1421-6.
[8] Nelson JE, Meier JE, Oei EJ, et al. Self-reported symptom experience
of critically ill cancer patients receiving intensive care. Crit Care Med
2001;29:277-82.
[9] Mostafa SM, Bhandari S, Ritchie G, et al. Constipation and its
implications in the critically ill patient. Br J Anaesth 2003;91:
815-9.
[10] Patanwala AE, Abarca J, Huckleberry Y, et al. Pharmacologic
management of constipation in the critically ill patient. Pharmacother-
apy 2006;26:896-902.
[11] van der Spoel JI, Schultz MJ, van der Voort PHJ, et al. Influence of
severity of illness, medication and selective tract decontamination.
Intensive Care Med 2006;32:875-80.
[12] Montejo J. Enteral nutrition-related gastrointestinal complications in
critically ill patients: a multicenter study. Crit Care Med 1999;27:
1447-53.
[13] Marshall JC, Nathens AB. The gut in critical illness: evidence from
human studies. Shock 1996;6(Suppl 1):S10-6.
[14] Carrasco G. Instruments for monitoring intensive care unit sedation.
Crit Care 2000;4:217-25.
[15] MacIntyre NR, Cook DJ, Ely Jr EW, et al. Evidence-based
guidelines for weaning and discontinuing ventilatory support: a
collective task force facilitated by the American College of Chest
Physicians; the American Association for Respiratory Care; and the
American College of Critical Care Medicine. Chest 2001;120:
375S-95S.
[16] van der Spoel JI, Oudemans-van Straaten HM, Kuiper MA, et al.
Laxation of critically ill patients with lactulose or polyethylene glycol:
a two-center randomized, double-blind, placebo-controlled trial. Crit
Care Med 2007;35:2726-31.
[17] Martindale RG, Maerz LL. Management of perioperative nutrition
support. Curr Opin Crit Care Med 2006;12:290-4.
[18] Staats PS, Markowitz J, Schein J. Incidence of constipation associated
with long-acting opioid therapy: a comparative study. South Med J
2004;97:129-34.
[19] Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release
oral morphine in cancer pain: preference, efficacy, and quality of life.
The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage
1997;13:254-61.
630.e12 A.P. Nassar Jr. et al.
... Besides, constipation diagnosis is frequently delayed due to it is considered a less severe complication in critically ill patients 4,16 compared to hemodynamic, respiratory, or renal problems. However, constipation has been related in critically ill adult patients to delirium 17 , higher illness clinical severity 13,18 , longer duration of mechanical ventilation (MV) 13 , ventilator weaning 19 , ICU and hospital length of stay 3,5,10,13,20,21 and higher hospital costs 5 . ...
... Constipation was defined as absence of defecation for more than 3 days after PICU admission 1,6,16,19 . Data analyzed included age, sex, weight, diagnosis and illness severity scores at admission: Pediatric Risk of Mortality III (PRISM III), Pediatric Index of Mortality 2 (PIM2), and Pediatric Logistic Organ Dysfunction (PELOD) [23][24][25] , length of PICU stay, and mortality. ...
... A very important barrier to performing epidemiology and treatment studies is the lack of universal diagnostic criteria for constipation 1,2,7,16,18,26 . International consensus about this item is focused in functional gastrointestinal disorders but there is no consensus about secondary constipation 8,9,27 . ...
Article
Full-text available
Constipation affects almost 50% of critically ill pediatric patients and is related to their morbidity and mortality. However, little attention is paid to it and it is diagnosed late and when there are already complications. The objective of this study is to develop and validate a score to identify critically ill children with high risk of constipation 48 h after admission. A single center two phase-study was carried out; the first one (retrospective observational study) to develop the score and the second one to validate it in another prospective observational study. Children between 15 days of life and 18 years old admitted to the PICU for more than 3 days were included. Demographic and clinical data during the first 48 h after PICU admission were collected. Univariate and multivariate analysis and ROC curves were used to develop and validate the score. Data from 145 patients (62.8% boys) with a mean age of 34.9 ± 7.3 months were used to develop the score. Independent factors identified to develop the score were: weight > 7 kg, admission to PICU after surgery, need of vasoconstrictors, doses of fentanyl ≥ 2 mcg/kg/h, and initiation of enteral nutrition later than 48 h after admission. Two cut-off values were identified to set low constipation risk (< 5.7 points) and high constipation risk (> 6.2 points). This score was validated in 124 patients showing a sensibility of 63.2%, specificity of 95.5% and a positive/negative predictive values (P/NPV) of 100% and 82.1% respectively to identify constipated patients. This is the first score to identify high constipation risk in critically ill children. This score is easy to apply, and internal validation has shown a PPV of 100%.
... 1,2) Several factors can contribute to constipation in critically ill patients, including immobility, dehydration, and the use of sedatives, opioids, and vasopressors. [3][4][5] The prevalence of constipation varies from 4.1% to 84%. 1,[6][7][8][9][10][11][12] A prevalence study conducted in an adult orthopedic setting demonstrated that 50% of the patients experienced constipation after orthopedic surgery. ...
... This prospective randomized controlled study comprised 165 patients aged above 65 years who were admitted to the orthopedic department for surgery and possibly had constipation 4,14) between August 2017 and December 2018. Of the 165 patients, 16 who were discharged within 5 days after surgery and 61 who took laxatives during the admission period were excluded. ...
Article
Background: This prospective randomized controlled study aimed to determine the effects of abdominal massage on constipation management in elderly patients with hip fractures. Methods: From August 2017 to December 2018, patients aged above 65 years with hip fractures (n = 88) were randomly assigned to a massage group that received a bowel massage (n = 48) or a control group that did not receive a bowel massage (n = 40). Patients in the bowel massage group received a bowel massage from a trained caregiver after breakfast at approximately 9:00 AM for an hour. On admission, 5 days after surgery, and on the day of discharge, the patient's normal and actual defecation pattern, stool consistency, and any problems with defecation were assessed through a structured interview. The questionnaire comprising the Bristol Stool Scale, patient assessment of constipation, time to defecation, medication for defecations, failure to defecate, cause of admission, admission period, and date of surgery were recorded. Statistical analyses were performed 5 days after surgery and on the day of discharge. Results: The mean age of the study cohort was 81.4 years (range, 65-99 years). The number of constipation remedies was significantly lower in the massage group than in the control group on postoperative day (POD) 5 and at discharge (9 vs. 15, p = 0.049 and 6 vs. 11, p = 0.039, respectively). The number of defecation failures was significantly lower in the massage group than in the control group (10 vs. 17, p = 0.028) on POD 5. However, the number of defecation failures at discharge was not significantly different between the two groups (p = 0.131). The development of postoperative ileus (p = 0.271) and length of hospital stay (p = 0.576) were not different between the groups. Conclusions: The number of constipation remedies was significantly lower in the massage group than in the control group on POD 5 and discharge, and the number of defecation failures was significantly lower in the massage group than in the control group on POD 5. Therefore, abdominal massage may be considered as an independent nursing initiative for constipation management.
... Although a constipated patient can develop complications that in very few cases could lead him to the ICU, what usually happens is that severe patients develop constipation, mainly in those who have undergone abdominal surgery or any type of surgery in which the intestine is manipulated importantly, electrolyte alterations, in those under anesthesia for a long time, those who use deep sedation, those who are under great metabolic stress as burned patients, with brain injury or sepsis. 3,6 There are some studies that have sought to identify some other factors that could lead to the development of this alteration in the evacuation rhythm, fasting, change of diet, and the use or not of prokinetics and laxatives play an important role. 4 In this issue of the Journal of Acute Care Jacob and Col present a study recently conducted in India, in which 61 patients with sepsis were included, it was a prospective observational study of adult patients admitted with sepsis to tertiary care, referral to ICU Bengaluru, over the period of 12 months from January to March 2018, who stayed three or more days. ...
... 5 There are no specific statistical data that tells us what percentage of patients admitted to the ICU develop constipation, but according to several publications we know that this figure can range from five to over 80%, of course, this is also conditioned by the type of patients received in the ICU. 3 For some years now we have known the relationship between patients who are mechanically ventilated in an invasive manner and constipation, causing these patients to stay more days on mechanical ventilation and in the ICU, although it is still difficult to know if this is a cause or a consequence. ...
... The American Gastroenterological Association has defined constipation as three bowel movements per week or less, a sense of incomplete evacuation, hard stools, difficulty in passing stools, or the need for manual maneuvers for evacuation. 1 Several factors are responsible for the increased frequency of constipation among the patients admitted to intensive care, such as shock, the use of sedatives and opioid agents, electrolyte imbalances, and diet changes. 2 Epidemiological studies have shown that the incidence of constipation in the ICU ranges from 5 to 83%. [3][4][5] The etiology of constipation also varies across studies. Time to the first defecation has been found to correlate with severity of illness, vasoactive agents, administration of morphine, cisapride and lactulose, duration of mechanical ventilation, and ICU length of stay. ...
... 11 Nassar Jr et al., found that initiating enteral feeding earlier may lead to an earlier return of bowel movements. 4 Laxative prophylaxis was also seen to successfully prevent constipation in ICU patients. Furthermore, bowel movement occurring 5 days or later is associated with fewer ventilator days observed by Masri et al. 12 A study by Guerra et al. showed an association between a lack of bowel movements during hospitalization and longer hospitalization time. ...
... One of the challenges of faeces collection for microbiome testing during hospitalisation is that bowel motions of patients are often infrequent, particularly in critically ill patients where up to 70% of patients may be constipated, hence unable to provide stool for analysis [3,4]. Rectal swabs may be an alternative solution for microbiome testing for such patients [5,6]. ...
... However, this study is described to assess the utility of rectal swabs collected with the specific aims addressing effects of antibiotics on the gut microbiome. The small number of samples available for analysis in this study reflects the challenge which the rectal swabs are able to assist in addressing, namely lack of faecal sample collection on regular intervals during intensive care admission [4]. ...
Article
Full-text available
Background The purpose of this study was to investigate the use of routinely available rectal swabs as a surrogate sample type for testing the gut microbiome and monitoring antibiotic effects on key gut microorganisms, of patients hospitalised in an intensive care unit. A metagenomic whole genome sequencing approach was undertaken to determine the diversity of organisms as well as resistance genes and to compare findings between the two sampling techniques. Results No significant difference was observed in overall diversity between the faeces and rectal swabs and sampling technique was not demonstrated to predict microbial community variation. More human DNA was present in the swabs and some differences were observed only for a select few anaerobes and bacteria also associated with skin and/or the female genitourinary system, possibly reflecting sampling site or technique. Antibiotics and collections at different times of admission were both considered significant influences on microbial community composition alteration. Detection of antibiotic resistance genes between rectal swabs and faeces were overall not significantly different, although some variations were detected with a potential association with the number of human sequence reads in a sample. Conclusion Testing the gut microbiome using standard rectal swab collection techniques currently used for multi-resistant organism screening has been demonstrated to have utility in gut microbiome monitoring in intensive care. The use of information from this article, in terms of methodology as well as near equivalence demonstrated between rectal swabs and faeces will be able to support and potentially facilitate the introduction into clinical practice.
... Constipation, a common complication in critically ill patients, is estimated to affect up to 70% of patients in the ICU setting [1]. Several factors, such as shock, dietary alterations, electrolyte disturbances, and common sedation and analgesia medications contribute to this issue [2]. ...
Article
Background Opioid-induced constipation (OIC) has become more common in the intensive care unit (ICU) due to increased opioid utilization. Traditional laxatives often prove ineffective against OIC, leading to the increased utilization of naloxegol. However, further research is needed to confirm naloxegol's effectiveness and safety in critical care. This study aimed to explore the safety and efficacy of this intervention in critically ill OIC patients. Methods A single-center retrospective study was conducted on 353 patients who received one or more doses of naloxegol from January 1, 2019, to June 30, 2020, for OIC at a tertiary care center. The primary endpoint of this study was to evaluate serious adverse events such as reduced analgesic effect, gastrointestinal perforation, seizure, acute myocardial infarction (AMI), or ventricular arrhythmias using Naranjo Scale in critically ill patients. The secondary goal was to assess the efficacy of naloxegol, measured by the time of the first bowel movement. Results The average duration of naloxegol use was three days, with the first bowel movement occurring at an average of 11.3 hours. Furthermore, 59.8% of individuals had their first bowel movement within 20 hours of receiving naloxegol. There was a low level of causality between naloxegol use and adverse events such as gastrointestinal perforation, seizures, AMI, cardiovascular mortality, stroke, and ventricular arrhythmia. Additionally, reduction in analgesia showed no strong relationship with naloxegol use indicated by the Naranjo Scale assessment. Conclusion Naloxegol showed promising safety and efficacy profiles in treating OIC amongst critically ill patients, though our findings require further validation through prospective studies. This research paves the way for further investigation into naloxegol's role in OIC management, emphasizing the necessity of personalized treatment strategies in critical care settings.
... [10] Constipation also affect breathing because of increased abdominal pressure. [11] Constipation has been found to be associated with delay in weaning from ventilator, [12] other studies have correlated constipation with higher incidence of infections, [13] multi-organ dysfunction, prolonged stay ICU, and overall increased mortality. [14] In our study, we also found very high prevalence of constipation and we also observed that it can be easily overlooked if not asked directly to patients. ...
Article
Full-text available
Background: Caregivers not being allowed into the COVID wards prevented them from being involved in caring for their relatives in respect of day-to-day activities such as eating, drinking, and walking to the washroom. The aim of this study was to observe the challenges faced by patients admitted to intensive care unit (ICU) with COVID-19 pneumonia. We also observed the impact of two simple nursing interventions related to feeding and defecation and noted their impact in terms of patient's satisfaction. Materials and Methods: A semi-structured feedback questionnaire was prepared to cover common challenges faced by patients after interview with 10 patients admitted at a COVID ICU. Two simple nursing interventions were performed related to feeding and defecation. Results: Breathlessness was the most common issue as all the patients admitted were hypoxic. Inability to perform routine day-to-day functions such as feeding, drinking, sitting, and walking were other common issues. Emotional issues like anxiety, fear homesickness, and loneliness were also very high. Most (69.44%) patients were satisfied with a blended diet which was easy to take for patients with breathlessness. Most (77.28%) of patients were satisfied with intervention of helping them sit on a commode chair while on oxygen. Conclusion: During this pandemic, where all our efforts seemed insufficient in face of this unprecedented crisis yet these small seemingly insignificant steps helped both the patients as well as nurses in making the atmosphere more positive.
Article
Background Constipation is frequent in critically ill patients, and potentially related to adverse outcomes. Peripherally‐active mu‐opioid receptor antagonists (PAMORAs) are approved for opioid‐induced constipation, but information on their efficacy and safety in critically ill patients is limited. We present a single‐center, retrospective, case‐series of the use of naldemedine for opioid‐associated constipation, and we systematically reviewed the use of PAMORAs in critically ill patients. Methods Case‐series included consecutive mechanically‐ventilated patients; constipation was defined as absence of bowel movements for >3 days. Naldemedine was administered after failure of the local laxation protocol. Systematic review: PubMed was searched for studies of PAMORAs to treat opioid‐induced constipation in adult critically ill patients. Primary outcomes: time to laxation, and number of patients laxating at the shortest follow‐up. Secondary outcomes: gastric residual volumes and adverse events. Key Results A total of 13 patients were included in the case‐series; the most common diagnosis was COVID‐19 ARDS. Patients had their first bowel movement 1 [0;2] day after naldemedine. Daily gastric residual volume was 725 [405;1805] before vs. 250 [45;1090] mL after naldemedine, p = 0.0078. Systematic review identified nine studies (two RCTs, one prospective case‐series, three retrospective case‐series and three case‐reports). Outcomes were similar between groups, with a trend toward a lower gastric residual volume in PAMORAs group. Conclusions & Inferences In a highly‐selected case‐series of patients with refractory, opioid‐associated constipation, naldemedine was safe and associated to reduced gastric residuals and promoting laxation. In the systematic review and meta‐analysis, the use of PAMORAs (mainly methylnaltrexone) was safe and associated with a reduced intolerance to enteral feeding but no difference in the time to laxation.
Article
Objectives: This meta-analysis evaluated the effect of opioids on constipation in ICU patients. Review method used: Systematic review and meta-analysis. Data sources: PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), and Wanfang DATA databases. Review methods: Random or fixed-effects meta-analyses were used. Subgroup analysis was performed according to the definition of constipation (three vs. six days), opioids (fentanyl vs. morphine), study design (prospective vs. retrospective), adjustment of confounders (No vs. Yes), and patient's age (adults vs. children). We used sensitivity analysis to test the robustness of results with significant statistical heterogeneity. Results: Seven studies (2264 patients) were included. Opioid use in ICU patients was associated with an increased risk of constipation (relative risk [RR]=1.14; 95% confidence interval [CI]=1.05 to 1.24; I2=49.8%). Subgroup analysis further showed that adjustment form, category of opioid, study design, and patient's age significantly influenced the relationship between opioid use and the risk of constipation. Sensitivity analysis confirmed the robustness of pooled results. Conclusion: Opioids significantly increase the risk of constipation in critically ill patients, especially children. It is worth noting that the adjustment of the constipation definition used for ICU significantly influenced the relationship between opioid use and the risk of constipation. Therefore, It is necessary to clearly define ICU constipation and conduct time-based layered treatment. Additional prospective studies are needed to investigate the consistent definition of ICU constipation.
Article
Full-text available
Objective: To compare the evaluation of the stressors present in the intensive care unit (ICU) from the point of view of the patient, relatives and the multiprofessional team and to identify differences and similarities with regard to the per-ception of stressors in order to opti-mize patient care. Design: Cross-sectional analytical survey. Setting: General ICU of a private hospital. Patients and participants: From April 1 st to June 30 th , 1996, 50 ICU patients during the first week of their ICU stay, 50 of their respective relatives and 50 members of the professional team directly involved in the care of these patients. Measurements and results: The In-tensive Care Unit Environmental Stressor Scale (ICUESS) was ad-ministered to all patients. The rela-tives and health care professionals were asked to complete the ICUESS on the basis of their perception of the patient's stressors. Being in pain, having tubes in the nose or mouth, being restrained by tubes and being unable to sleep were considered by the patients, relatives and health care professionals as the main stres-sors. The professional team evaluat-ed the intensity of the stressors higher than either the family or the patient. No statistical significance was detected between the intensity of the stressors as evaluated by the patient and the intensity evaluated by relatives and by the professional team. Conclusions: Being in pain, being unable to sleep and having tubes in the nose and/or mouth were pointed out as the major stressors by the three groups. There was no statisti-cally significant correlation between the total stress scores of the patients and their relatives (r = 0.193), be-tween the patients and the team (r = ±0.002), or between the total scores of the team and the relatives (r = ±0.185). The results suggest that the views of the relatives and the professional team concerning the stressors have some similar points compared to the evaluation made by the patient himself, although the in-tensity of the evaluation for each group corresponds to its own per-ception.
Article
Full-text available
To compare the evaluation of the stressors present in the intensive care unit (ICU) from the point of view of the patient, relatives and the multiprofessional team and to identify differences and similarities with regard to the perception of stressors in order to optimize patient care. Cross-sectional analytical survey. General ICU of a private hospital. From April 1st to June 30th, 1996, 50 ICU patients during the first week of their ICU stay, 50 of their respective relatives and 50 members of the professional team directly involved in the care of these patients. The Intensive Care Unit Environmental Stressor Scale (ICUESS) was administered to all patients. The relatives and health care professionals were asked to complete the ICUESS on the basis of their perception of the patient's stressors. Being in pain, having tubes in the nose or mouth, being restrained by tubes and being unable to sleep were considered by the patients, relatives and health care professionals as the main stressors. The professional team evaluated the intensity of the stressors higher than either the family or the patient. No statistical significance was detected between the intensity of the stressors as evaluated by the patient and the intensity evaluated by relatives and by the professional team. Being in pain, being unable to sleep and having tubes in the nose and/or mouth were pointed out as the major stressors by the three groups. There was no statistically significant correlation between the total stress scores of the patients and their relatives (r = 0.193), between the patients and the team (r = -0.002), or between the total scores of the team and the relatives (r = -0.185). The results suggest that the views of the relatives and the professional team concerning the stressors have some similar points compared to the evaluation made by the patient himself, although the intensity of the evaluation for each group corresponds to its own perception.
Article
Full-text available
Although many promising objective methods (measuring systems) are available, there are no truly validated instruments for monitoring intensive care unit (ICU) sedation. Auditory evoked potentials can be used only for research in patients with a deep level of sedation. Other measuring systems require further development and validation to be useful in the ICU. Continuing research will provide an objective system to improve the monitoring and controlling of this essential treatment for ICU patients. Subjective methods (scoring systems) that are based on clinical observation have proven their usefulness in guiding sedative therapy. The Glasgow Coma Score modified by Cook and Palma (GCSC) achieves good face validity and reliability, which assures its clinical utility for routine practice and research. Other scales, in particular the Ramsay Scale, can be recommended preferably for clinical use. An accurate use of available instruments can improve the sedative treatment that we deliver to our patients.
Article
Chronic constipation is a prevalent condition that severely impacts the quality of life of those affected. Several types of primary chronic constipation, which show substantial overlap, have been described, including normal-transit constipation, rectal evacuation disorders and slow-transit constipation. Diagnosis of primary chronic constipation involves a multistep process initiated by the exclusion of ‘alarm’ features (for example, unintentional weight loss or rectal bleeding) that might indicate organic diseases (such as polyps or tumours) and a therapeutic trial with first-line treatments such as dietary changes, lifestyle modifications and over-the-counter laxatives. If symptoms do not improve, investigations to diagnose rectal evacuation disorders and slow-transit constipation are performed, such as digital rectal examination, anorectal structure and function testing (including the balloon expulsion test, anorectal manometry or defecography) or colonic transit tests (such as the radiopaque marker test, wireless motility capsule test, scintigraphy or colonic manometry). The mainstays of treatment are diet and lifestyle interventions, pharmacological therapy and, rarely, surgery. This Primer provides an introduction to the epidemiology, pathophysiological mechanisms, diagnosis, management and quality of life associated with the commonly encountered clinical problem of chronic constipation in adults unrelated to opioid abuse.
Article
Objective: To evaluate the frequency of gastrointestinal complications (GICs) in a prospective cohort of critically ill patients receiving enteral nutrition and to assess its effect on nutrient administration and its relationship to the patient's outcome. Design: Multicenter, prospective cohort study. Setting: Thirty-seven multidisciplinary intensive care units (ICUs) in Spain. Patients: Prospective cohort of 400 consecutive patients admitted to the ICU and receiving enteral nutrition. Interventions: Noninterventional, follow-up study. Measurements and Main Results: Enteral nutrition-related GICs and their management were defined by consensus before data collection. A set of variables related to enteral nutrition administration and the presence of GICs was recorded. During the 1-month study period, 400 patients were enrolled, and a total of 3,778 enteral feeding days were analyzed. The mean time of enteral nutrition was 9.6 +/- 0.4 days. Mean elapsed time from ICU admission to the start of enteral feeding was 3.1 +/- 0.2 days. A total of 265 patients (66.2%) received a standard polymeric formula, and 132 (33.8%) received a disease-specific one, Enteral feeds were administered mainly through a nasogastric tube (91%). One or more GICs were presented by 251 patients (62.8%) during the feeding course, The frequency of each particular GIC was as follows: high gastric residuals, 39%; constipation, 15.7%; diarrhea, 14.7%; abdominal distention, 13.2%; vomiting, 12.2%; and regurgitation, 5.5%, Enteral nutrition withdrawal as a consequence of noncontrollable GICs occurred in 15.2% of patients. The volume ratio (expressed as the ratio between administered and prescribed volumes) was calculated daily and was used as an index of diet administration efficacy, Patients with GICs had a lower volume ratio than did patients without GICs (63.1 +/- 1.2% vs. 93.3 +/- 0.3%) (p < .001), a longer length of stay (20.6 +/- 1.2 vs. 15.2 +/- 1.3 days) (p < .01), and higher mortality (31% vs. 16.1%) (p < .001), Conclusions: The frequency of enteral nutrition-related GICs in critically ill patients is high, High gastric residuals is the most frequent GIG. These complications decreased nutrient intake and, if persistent, could expose the patients to undernutrition, Enteral feeding gastrointestinal intolerance seems to have an evolutive effect in prolonging the ICU stay and increasing patient mortality.
Article
Data from a large number of published human studies support the hypothesis that the gastrointestinal tract of the critically ill patient is an important factor in ICU morbidity and mortality. Changes in proximal gut flora in the critically ill patient predict nosocomial infection with the same organism, while gut-directed therapeutic measures clearly reduce rates of nosocomial infection and may have an impact on mortality Modulation of the systemic inflammatory response through gut derived measures has been no more successful than modulation of that response through more conventional systemic forms of mediator-directed therapy. But if the gastrointestinal tract is an important factor in nosocomial ICU-acquired infection, the bigger unanswered question is, to what extent does infection per se alter outcome in critical illness? Current articulations of the gut hypothesis challenge long-held and probably outmoded views of host-microbial interactions. The challenge to replace them is no less compelling and no less treacherous than it was in the era of Metchnikoff, Lane, or their ancient forebears.
Article
Cancer patients requiring strong opioid analgesia (n = 202; mean age, 61.5 years; range, 18-89 years; 55% men) were recruited from 38 United Kingdom palliative care centers into a randomized, open, two-period, crossover study comparing transdermal fentanyl with sustained-release oral morphine. Patients received one treatment for 15 days followed immediately by the other for 15 days. Daily diaries were completed. Both treatments appeared equally effective in terms of pain control, as assessed by the Memorial Pain Assessment Card and European Organization for Research and Treatment of Cancer (EORTC) pain scores. Fentanyl was associated with significantly less constipation (p < 0.001) and less daytime drowsiness (p = 0.015) but greater sleep disturbance (p = 0.004) and shorter sleep duration (p = 0.008) than morphine. The World Health Organization (WHO) performance status and EORTC global quality of life scores showed no significant difference between treatment groups. Of those patients who were able to express a preference (n = 136), significantly more preferred the fentanyl patches (p = 0.037). We conclude that, in this study, transdermal fentanyl provided pain relief that was acceptable to cancer patients and was associated with less constipation and sedation than morphine. These reduced side effects may contribute to patients preference for the patches.
Article
To evaluate the frequency of gastrointestinal complications (GICs) in a prospective cohort of critically ill patients receiving enteral nutrition and to assess its effect on nutrient administration and its relationship to the patient's outcome. Multicenter, prospective cohort study. Thirty-seven multidisciplinary intensive care units (ICUs) in Spain. Prospective cohort of 400 consecutive patients admitted to the ICU and receiving enteral nutrition. Noninterventional, follow-up study. Enteral nutrition-related GICs and their management were defined by consensus before data collection. A set of variables related to enteral nutrition administration and the presence of GICs was recorded. During the 1-month study period, 400 patients were enrolled, and a total of 3,778 enteral feeding days were analyzed. The mean time of enteral nutrition was 9.6+/-0.4 days. Mean elapsed time from ICU admission to the start of enteral feeding was 3.1+/-0.2 days. A total of 265 patients (66.2%) received a standard polymeric formula, and 132 (33.8%) received a disease-specific one. Enteral feeds were administered mainly through a nasogastric tube (91%). One or more GICs were presented by 251 patients (62.8%) during the feeding course. The frequency of each particular GIC was as follows: high gastric residuals, 39%; constipation, 15.7%; diarrhea, 14.7%; abdominal distention, 13.2%; vomiting, 12.2%; and regurgitation, 5.5%. Enteral nutrition withdrawal as a consequence of noncontrollable GICs occurred in 15.2% of patients. The volume ratio (expressed as the ratio between administered and prescribed volumes) was calculated daily and was used as an index of diet administration efficacy. Patients with GICs had a lower volume ratio than did patients without GICs (63.1+/-1.20% vs. 93.3+/-0.3%) (p < .001), a longer length of stay (20.6+/-1.2 vs. 15.2+/-1.3 days) (p < .01), and higher mortality (31% vs. 16.1%) (p < .001). The frequency of enteral nutrition-related GICs in critically ill patients is high. High gastric residuals is the most frequent GIC. These complications decreased nutrient intake and, if persistent, could expose the patients to undernutrition. Enteral feeding gastrointestinal intolerance seems to have an evolutive effect in prolonging the ICU stay and increasing patient mortality.